BIOGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 235.3 USD | +3.72% |
|
+7.10% | -9.06% |
| 05-15 | Sector Update: Health Care Stocks Advance Late Wednesday Afternoon | MT |
| 05-15 | Sector Update: Health Care Stocks Advance in Afternoon Trading | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
Pharmaceuticals
Calendar
20/06/2024
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
226.9
USD
Average target price
285.9
USD
Spread / Average Target
+26.02%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -9.06% | 33.03B | |
| -1.26% | 89.46B | |
| +2.76% | 40.74B | |
| +55.32% | 24.68B | |
| -16.61% | 15.12B | |
| -9.14% | 12.81B | |
| -12.11% | 11.79B | |
| -43.61% | 11.64B | |
| +7.79% | 8.9B | |
| -7.72% | 8.22B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Sector Update: Health Care Stocks Slipping Late Friday
